Sökning: onr:"swepub:oai:DiVA.org:uu-50726" >
Opioid effects on 4...
-
Vlaskovska, Mila
(författare)
Opioid effects on 45Ca2+ uptake and glutamate release in rat cerebral cortex in primary culture
- Artikel/kapitelEngelska1997
Förlag, utgivningsår, omfång ...
-
2002-11-18
-
Wiley,1997
-
printrdacarrier
Nummerbeteckningar
-
LIBRIS-ID:oai:DiVA.org:uu-50726
-
https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-50726URI
-
https://doi.org/10.1046/j.1471-4159.1997.68020517.xDOI
-
http://kipublications.ki.se/Default.aspx?queryparsed=id:1949913URI
Kompletterande språkuppgifter
-
Språk:engelska
-
Sammanfattning på:engelska
Ingår i deldatabas
Klassifikation
-
Ämneskategori:ref swepub-contenttype
-
Ämneskategori:art swepub-publicationtype
Anmärkningar
-
Primary cultures of rat cortex, conveniently prepared from newborn animals, were used to study opioid effects on 45Ca2+ uptake and glutamate release. 45Ca2+ uptake, induced by treatment with glutamate or NMDA, was largely blocked by the NMDA antagonist MK-801. K+ depolarization-induced 45Ca2+ uptake was also reduced by MK-801, indicating that the effect was mediated by glutamate release. Direct analysis verified that glutamate, and aspartate, were indeed released. Opioid peptides of the prodynorphin system were also released and these, or other peptides, were functionally active, because naloxone treatment increased glutamate release, as well as the 45Ca2+ uptake induced by depolarization. Opioid agonists, selective for mu-, kappa-, and delta-receptors, inhibited the 45Ca2+ uptake induced by K+ depolarization. The combination of low concentrations of MK-801 and opioid agonists resulted in additive inhibition of K(+)-induced 45Ca2+ uptake. The results indicate that this system may be useful as an in vitro CNS model for studying modulation by opioids of glutamate release and Ca2+ uptake under acute, and perhaps also chronic, opiate treatment.
Ämnesord och genrebeteckningar
Biuppslag (personer, institutioner, konferenser, titlar ...)
-
Schramm, Michael
(författare)
-
Nylander, IngridDepartment of Clinical Neuroscience, Experimental Alcohol and Drug Addiction Research Section, Karolinska Institute,Pharmacology(Swepub:uu)iny08577
(författare)
-
Kasakov, Lubomir
(författare)
-
You, Zhi-Bing
(författare)
-
Herrera-Marschitz, Mario
(författare)
-
Terenius, LarsKarolinska Institutet
(författare)
-
HerreraMarschitz, M
(författare)
-
Department of Clinical Neuroscience, Experimental Alcohol and Drug Addiction Research Section, Karolinska InstitutePharmacology
(creator_code:org_t)
Sammanhörande titlar
-
Ingår i:Journal of Neurochemistry: Wiley68:2, s. 517-5240022-30421471-4159
Internetlänk
Hitta via bibliotek
Till lärosätets databas